Nature Communications (Feb 2016)
A monoclonal antibody against KCNK9 K+ channel extracellular domain inhibits tumour growth and metastasis
Abstract
The potassium channel KCNK9 mediates important biological processes and is often overexpressed in breast and lung cancers. In this study, the authors developed a specific monoclonal antibody against the extracellular domain of KCNK9 and show that it inhibits cancer growth and metastasis in vivothrough both cell autonomous and immune-dependent cellular cytotoxicity.